Carlyle Group Inc.

CIK 0001527166

3 SPACs with a current declared position, filed between Feb 12, 2024 and Nov 12, 2024. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Nov 12, 2024. Read the page below as a record of what was declared, not as a register of what is held.

Filed under 1 earlier name

Carlyle Group L.P.EDGAR’s own former-name record for CIK 0001527166. The page did not move when the filer renamed, because the identity is the CIK and the URL is a label it owns.

SPACs declared

every position whose latest statement stands — the record

Re-affirmed in 12 months

filed inside 365 days — what a reader means by "owns"

Still live

positions in SPACs still searching or in an announced deal

Median stake

7.1%

no percentage stated on the cover pages

1 passive (13G)2 activist (13D)52 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column

3 of 3 shown · 3 positions have not been amended in over a year

	SPAC			Voting	Dispositive			Source
CSLR	Freedom Acquisition I Corp.16 reporting persons on this schedule	10.9%	8,107,842	0 / 8,107,842	0 / 8,107,842	Closed (deSPAC)	Nov 12, 2024Stale	SC 13G/A0001493152-24-044784 32 earlier statements
AMHC	Amplitude Healthcare Acquisition Corp10 reporting persons on this schedule	7.1%	1,066,189	0 / 1,066,189	0 / 1,066,189	Closed (deSPAC)	Feb 12, 2024Stale	SC 13D/A · may seek to influence control0001193125-24-032344 20 earlier statements
JWS	Jaws Acquisition Corp.8 reporting persons on this schedule	6.7%	2,801,906	0 / 2,801,906	0 / 2,801,906	Closed (deSPAC)	Jul 8, 2024Stale	SC 13D · may seek to influence control0001193125-24-176400

52 superseded statements (newest 4 shown)

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

CSLR Freedom Acquisition I Corp.17.7% · SC 13G/A Jul 11, 2024replaced Nov 12, 2024 by 0001493152-24-044784
CSLR Freedom Acquisition I Corp.5.7% · SC 13G Sep 22, 2023replaced Jul 11, 2024 by 0001193125-24-177760
AMHC Amplitude Healthcare Acquisition Corp8.0% · SC 13D/A Jan 31, 2023replaced Feb 12, 2024 by 0001193125-24-032344
AMHC Amplitude Healthcare Acquisition Corp15.4% · SC 13D/A Aug 11, 2022replaced Jan 31, 2023 by 0001193125-23-020358

Reporting persons on this filer's schedules

one filer, several names — collapsed once, shown in full

A joint Schedule 13 names every person who beneficially owns the shares — the management company, the funds it advises, the general partner and often the individual who controls all three. They report the same shares. Counting them separately would publish this filer’s footprint two or three times over, so they are counted once, under CIK 0001527166. This filer has named 21 of them across the schedules in the table above:

Abingworth
Abingworth Bioventures VII
CG Subsidiary Holdings
CRSEF Lux GP S. r.l
CRSEF Managing GP
CRSEF Solis Holdings
Carlyle CLO Management
Carlyle CRSEF Solis Aggregator, S.C.Sp
Carlyle Genesis UK
Carlyle Holdings I
Carlyle Holdings I GP
Carlyle Holdings I GP Sub
Carlyle Holdings II
Carlyle Holdings II GP
Carlyle Investment Management
Crsef Gp
TC Group
TC Group Cayman Investment Holdings
TC Group Cayman Investment Holdings Sub
TC Group Sub
The Carlyle Group

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.